ClinicalTrials.gg
Drug

Flumatinib clinical trials

Includes 2 studies of Flumatinib mesylate.

studies test it
11
open now
3
in phase 3
2
first study started
2011

How each study uses flumatinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the flumatinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Flumatinib
7

Development codes

HHGV678
1

Studies by the year they started

11 studies that test it; most in 2021 (4)

Studies that test flumatinib, by start year
YearStudies
20111
20131
20141
20201
20214
20222
20241

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 5

Jiangsu Hansoh Pharmaceutical Co., Ltd. (5) · Shenzhen Second People's Hospital (2) · The First Affiliated Hospital of Soochow University (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Zhongda Hospital (1) · Jiangsu HengRui Medicine Co., Ltd. (1)

Often tested with

Tested in the same studies.

Azacitidine (1) · Venetoclax (1) · Embibatinib (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Flumatinib is the comparator. A study of two new drugs counts under both.

  • 1Embibatinib · Jiangsu Hansoh Pharmaceutical Co., Ltd. · next primary completion Jul 2029
Reaching primary completion within a year · 1

Studies that test flumatinib.

Studies

Open first, then newest update. How each study uses flumatinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

As the comparator · 1 — what is tested is compared with flumatinib

Codes

What other systems call flumatinib · ClinicalTrials.gg INT005734

  • MeSH (NLM) C553360flumatinibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) R4009Y24AIFLUMBATINIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q27287759flumatinibConfirmed FDA, NLM, Wikidata
  • DrugBank DB11904One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.